UPDATE : Monday, September 7, 2020
상단여백
248 drugs taken off the market for low profitability by Kwak Sung-sun 2017-07-28 16:39
Chinese control of biological resources alerts Korean drugmakers by Nam Doo-hyun 2017-07-28 14:14
Domestic pharmaceuticals’ Q2 earnings surprise investors by Constance Williams 2017-07-28 12:05
Green Cross’ 2Q operating profit jumps 43.6% by Lee Hye-seon 2017-07-27 16:35
Celltrion show record-high performances in Q2 by Nam Doo-hyun 2017-07-27 15:51
라인
Ildong’s 3-compound hypertension drug wins approval by Lee Hye-seon 2017-07-27 11:15
Samsung Bioepis makes most of US ruling on biosimilars by Marian Chu 2017-07-26 10:39
Merck succeeds in P3 trial for HIV-1 infection drug by Marian Chu 2017-07-26 10:32
Dong-A ST hit by penalty for illegal rebates by Marian Chu 2017-07-25 13:55
Hanmi expects blockbuster from hypertension-hyperlipidemia complex by Lee Hye-seon 2017-07-25 13:55
라인
Huons’ saline injection gets ANDA approval from FDA by Constance Williams 2017-07-24 15:25
GSK launches Internet portal for healthcare professionals by Marian Chu 2017-07-24 12:05
Saxenda lands in Korea as obesity therapy by Lee Hye-seon 2017-07-24 11:45
Daewoong's Botox product accepted for review by EMA, FDA by Constance Williams 2017-07-21 16:43
Hand, arm transplants to come under state management by Marian Chu 2017-07-21 11:06
라인
Pfizer Korea launches new Centrum products by Constance Williams 2017-07-20 15:22
Ministry ferrets out fake erectile dysfunction, obesity drugs by Marian Chu 2017-07-19 17:03
Hanmi’s Esomezol is 1st Korean drug enrolled on US Pharmacopoeia by Marian Chu 2017-07-19 11:42
Gilead gets FDA approval for hepatitis C drug by Marian Chu 2017-07-19 10:29
Global clinical trials decline but Korea’s share rises by Lee Hye-seon 2017-07-18 16:54
여백
여백
여백
Back to Top